Stay updated on BI 836858 & Decitabine Combo in AML Clinical Trial
Sign up to get notified when there's something new on the BI 836858 & Decitabine Combo in AML Clinical Trial page.

Latest updates to the BI 836858 & Decitabine Combo in AML Clinical Trial page
- CheckyesterdayChange DetectedThe footer now identifies the site as revision v3.8.0 instead of v3.7.2. The study-record area still displays a 403 Forbidden error.SummaryDifference0.2%

- Check8 days agoChange DetectedA banner announces an NIH website terminology transition, noting that both “Artificial Intelligence” and “Super Intelligence” may appear during the transition.SummaryDifference1%

- Check15 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier was updated from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating access to the study record is blocked. The layout shows the standard ClinicalTrials.gov header and footer, but the main content area presents the error instead of the study details.SummaryDifference19%

- Check64 days agoChange DetectedThe page revision has been updated from v3.6.5 to v3.6.6, signaling a new version of the page. This update is a metadata change and does not alter the study details or eligibility information presented.SummaryDifference0.1%

Stay in the know with updates to BI 836858 & Decitabine Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 836858 & Decitabine Combo in AML Clinical Trial page.